World-Class R&D for Market-Defining Devices
Wipro designs, develops, tests and validates products for medical device manufacturers. As the world’s largest 3rd party R&D service provider with 500+ customers, our 18,000+ consultants, experienced in working with key regulatory agencies in the US, Europe, Japan, China and Australia, do this by leveraging our expertise in software, mechanical and electronics engineering plus our partnerships with biomedical academics, hospitals, research institutions and industrial design houses. Clients using our R&D capabilities accelerate their time to market with services that include:
Moving towards patient centricity
Streamlining and standardizing processes
The purpose of this paper is to describe the importance of Risk Analysis, Risk Management Process, Application of Risk Management tools, and the benefit of the Risk Management Analysis.
How sustainable growth through innovation and market repositioning can drive the MedTech industry in India forward
The need for “plug-and-play” interoperability – the ability to take a medical device out of its box and easily make it work with one’s other devices or applications– has attracted great attention from both healthcare providers and industry.
Medical devices companies weave new business models to provide value-added services
Explore how M2M enables proactive service, allows for consumption-based business models and drives recurring revenue and improved customer experience
© 2021 Wipro Limited |
|
© 2021 Wipro Limited |
Pharmaceutical & Life Sciences